Seres Therapeutics Inc (MCRB) — Free Cash Flow Generation Index
Seres Therapeutics Inc (MCRB) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of $2.20 Million represents 1% of operating cash flow ($2.21 Million). Read MCRB current and long-term liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Seres Therapeutics Inc Free Cash Flow Generation Index (2016–2025)
Historical FCF Generation Index trend for Seres Therapeutics Inc across 3 annual periods. Explore MCRB capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Seres Therapeutics Inc (2016–2025)
Year-by-year Free Cash Flow Generation Index for Seres Therapeutics Inc. For the full company profile including market capitalisation, see market cap of Seres Therapeutics Inc.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.77x | $865.00K | $1.12 Million | $252.00K | ▲ +280.0% |
| 2021 | -0.43x | $-2.88 Million | $6.69 Million | $9.57 Million | ▼ -184.3% |
| 2016 | 0.51x | $22.43 Million | $43.92 Million | $21.49 Million | — |